Company / Return on Assets (ROA)
Rani Therapeutics Holdings, Inc. Return on Assets (ROA) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-51.2%
FY2025
5-year range
-92.7% / -6.7%
FY2021-FY2025
Trend
+44.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 2 years of decline, reaching -51.2%.
Based on SEC 10-K filings.
-51.2% in FY2025 with a 3-year CAGR of -43.5%.
Declined from -7.7% to -51.2% over the past 3 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -43.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 44.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -51.2% | +44.8% |
| FY2024 | -92.7% | -1102.7% |
| FY2022 | -7.7% | -14.9% |
| FY2021 | -6.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026